Partnering with multi-disciplinary breast cancer care teams, we are working to overcome the complex challenges of early-stage breast cancer. Genomic testing is a fundamental tool as we approach each decision. It has the unique ability to illuminate an individual’s tumor biology and help guide more personalized treatment strategies.

We have designed our tests to deliver rapid results that you can leverage in patient consultations before and after surgery. Covered by most healthcare plans, they serve as part of our effort to ease financial burdens for patients and expand testing access around the globe.